AXSM
Axsome Therapeutics
$144.06
−$0.99 (−0.68%)Oct 26, 2026
Key metrics
The numbers that frame AXSM today
- Market cap
- $7.55B
- Gross margin
- 93.2%
- EV / Sales
- 9.6
- ROIC
- -127.7%
- Div yield
- 0%
- Debt / equity
- 2.6
- 52wk Low
- $123.50
- 52wk High
- $260.19
Growth
Revenue and earnings trend for AXSM
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about AXSM
Is Axsome Therapeutics a good buy?
Hold. Axsome Therapeutics has excellent momentum, but weak quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Axsome Therapeutics is selling at a high price.
What is the market capitalization of AXSM?
Axsome Therapeutics's market capitalization is $7.55B.
What is the 52-week high for AXSM stock?
The 52-week high for Axsome Therapeutics is $260.19. The current close of $144.06 is 44.6% below that high.
What is the 52-week low for AXSM stock?
The 52-week low for Axsome Therapeutics is $123.50. The current close of $144.06 is 16.6% above that low.
Does AXSM stock pay dividends?
Axsome Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for AXSM?
Axsome Therapeutics's Debt / Equity ratio is 2.63.